EBITDA surged 25% to ₹4,192.2 crore and the EBITDA margin stood at 30.7% in the reporting quarter compared to 27.1% in the year-ago period. Shares of Sun Pharmaceutical Industries Ltd ended at ₹1,743.10, down by ₹2.15, or 0.12%, on the BSE.

EBITDA surged 25% to ₹4,192.2 crore and the EBITDA margin stood at 30.7% in the reporting quarter compared to 27.1% in the year-ago period. Shares of Sun Pharmaceutical Industries Ltd ended at ₹1,743.10, down by ₹2.15, or 0.12%, on the BSE.
+91 888 718 7394